Non-peptide antigens activating human Vγ9/Vδ2 T lymphocytes
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 95 (2) , 129-138
- https://doi.org/10.1016/j.imlet.2004.06.013
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Statins may potentiate bisphosphonates anticancer properties: a new pharmacological approach?Medical Hypotheses, 2003
- Isoprenoid biosynthesis via the methylerythritol phosphate pathway: the (E)‐4‐hydroxy‐3‐methylbut‐2‐enyl diphosphate reductase (LytB/IspH) from Escherichia coli is a [4Fe–4S] proteinFEBS Letters, 2003
- Identification of (E)‐4‐hydroxy‐3‐methyl‐but‐2‐enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coliFEBS Letters, 2001
- Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial DrugsScience, 1999
- Epidermal Growth Factor Stimulates 3-Hydroxy-3-Methylglutaryl-coenzyme A Reductase Expression via the ErbB-2 Pathway in Human Breast Adenocarcinoma CellsBiochemical and Biophysical Research Communications, 1999
- Sentinel function of broadly reactive human γδ T cellsImmunology Today, 1997
- Direct presentation of non-peptide prenyl pyrophosphate antigens to human γδ T cellsResearch in Immunology, 1996
- Human γδ T cells in tuberculosisResearch in Immunology, 1996
- Stimulation of γδ T cells by phosphoantigensResearch in Immunology, 1996
- Human Vγ9‐Vδ2 cells are stimulated in a crossreactive fashion by a variety of phosphorylated metabolitesEuropean Journal of Immunology, 1995